BUSULPHAN-MELPHALAN VERSUS CARBOPLATIN-ETOPOSIDE-MELPHALAN CONDITIONING REGIMEN IN CHILDREN WITH NEUROBLASTOMA UNDERWENT AUTOLOGOUS STEM CELL TRANSPLANTATION

被引：0
|
作者：
Atas, E. [1 ]
Kesik, V. [1 ]
Babacan, O. [1 ]
Korkmazer, N. [2 ]
机构：
[1] Gulhane Mil Med Acad, Dept Pediat Oncol, Ankara, Turkey
[2] Gulhane Mil Med Acad, Dept Pediat, Ankara, Turkey
来源：
BONE MARROW TRANSPLANTATION | 2014年 / 49卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
PH-P219
引用
收藏
页码：S206 / S206
页数：1
相关论文
共 50 条
  • [41] Autologous stem cell transplantation with high dose melphalan conditioning regimen is safe for elderly multiple myeloma patients
    Czyz, Anna
    Szeremet, Agnieszka
    Bogucka-Fedorczuk, Aleksandra
    Majcherek, Maciej
    Rybka, Justyna
    Prajs, Iwona
    Wrobel, Tomasz
    BONE MARROW TRANSPLANTATION, 2019, 54 : 499 - 500
  • [42] Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015)
    Jung, Sung-Hoon
    Lee, Je-Jung
    Kim, Mihee
    Min, Chang-Ki
    Lee, Ji Yun
    Jo, Jae-Cheol
    Yoon, Sung-Soo
    Lim, Sung-Nam
    Do, Young Rok
    Kim, Kihyun
    Lee, Jae Hoon
    Yoo, Kwai Han
    Bae, Sung Hwa
    Yi, Jun Ho
    Jung, Jongheon
    Eom, Hyeon-Seok
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S115 - S115
  • [43] Thiotepa and melphalan as a new conditioning regimen for autologous transplantation in multiple myeloma
    Grimaldi, F.
    Madonna, E.
    Avilia, S.
    Pane, F.
    Risitano, A. M.
    De Rosa, G.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S209 - S209
  • [44] Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015)
    Mihee Kim
    Je-Jung Lee
    Chang-Ki Min
    Ji Yun Lee
    Jae-Cheol Jo
    Sung-Soo Yoon
    Sung-Nam Lim
    Young Rok Do
    Kihyun Kim
    Jae Hoon Lee
    Kwai Han Yoo
    Sung Hwa Bae
    Jun Ho Yi
    Jongheon Jung
    Hyeon-Seok Eom
    Sung-Hoon Jung
    Annals of Hematology, 2023, 102 : 2233 - 2240
  • [45] Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015)
    Kim, Mihee
    Lee, Je-Jung
    Min, Chang-Ki
    Lee, Ji Yun
    Jo, Jae-Cheol
    Yoon, Sung-Soo
    Lim, Sung-Nam
    Do, Young Rok
    Kim, Kihyun
    Lee, Jae Hoon
    Yoo, Kwai Han
    Bae, Sung Hwa
    Yi, Jun Ho
    Jung, Jongheon
    Eom, Hyeon-Seok
    Jung, Sung-Hoon
    ANNALS OF HEMATOLOGY, 2023, 102 (08) : 2233 - 2240
  • [46] Overall survival in advanced stage mantle cell lymphoma after early autologous stem cell transplantation with cisplatin, etoposide, cytarabine and melphalan (peam) as a conditioning regimen
    Franco-Saenz, D.
    Acosta-Maldonado, B. L.
    Tellez-Manriquez, J. F.
    Valero-Saldana, L. M.
    Gutierrez-Gutierrez, B.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 171 - 171
  • [47] Comparable safety profile of BeEAM (bendamustine, etoposide, cytarabine, melphalan) and BEAM (carmustine, etoposide, cytarabine, melphalan) as conditioning before autologous haematopoietic cell transplantation
    Frankiewicz, Andrzej
    Sadus-Wojciechowska, Maria
    Najda, Jacek
    Czerw, Tomasz
    Mendrek, Wlodzimierz
    Sobczyk-Kruszelnicka, Malgorzata
    Soska, Katarzyna
    Ociepa, Malgorzata
    Holowiecki, Jerzy
    Giebel, Sebastian
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2018, 22 (02): : 113 - 117
  • [48] FEASIBILITY AND SAFETY OF BENDAMUSTINE, ETOPOSIDE, CYTARABINE, MELPHALAN (BEEAM) CONDITIONING REGIMEN BEFORE AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) IN 33 PATIENTS WITH MALIGNANT LYMPHOMA
    Bedoui, M.
    Brault, P.
    Glaisner, S.
    Shamieh, R. Elias
    Kuhnowski, F.
    HAEMATOLOGICA, 2016, 101 : 861 - 861
  • [49] Overall Survival in Advanced Stage Mantle Cell Lymphoma after Early Autologous Stem Cell Transplantation with Cisplatin, Etoposide ,Cytarabine and Melphalan (PEAM) As a Conditioning Regimen
    Franco, Daniel
    Tellez, Fernando
    Solis-Armenta, Ruben
    Leal Alanis, Araceli
    Cruz Castillo, Carlos
    Valero Saldana, Luis Manuel
    Acosta Maldonado, Brenda Lizeth
    BLOOD, 2023, 142
  • [50] Autologous Stem Cell Transplantation with Bendaeam (Bendamustine, Etoposide, Cytarabine, Melphalan) As Conditioning Regimen for Non-Hodgkin's Lymphoma and Hodgkin's Lymphoma
    Garciaz, Sylvain
    Coso, Diane
    Broussais, Florence
    Schiano, Jean-Marc
    Calmels, Boris
    Saillard, Colombe
    Boudin, Lauris
    Amrane, Sophie
    Blaise, Didier
    Bouabdallah, Reda
    BLOOD, 2014, 124 (21)
12345